Kinnate BioPharma Inc.(KNTE)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KNTE Kinnate BioPharma Inc.

停牌 05-10 12:20:31 EDT

2.65

+0.00

0.00%

最高2.65	最低2.65	成交量0.00
今开2.65	昨收2.65	日振幅0.00%
总市值1.25亿	流通市值6,024万	总股本4,723万
成交额746.65万	换手率0.00%	流通股本2,273万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"KNTE","market":"US","secType":"STK","nameCN":"Kinnate BioPharma Inc.","latestPrice":2.65,"timestamp":1712088000000,"preClose":2.65,"halted":3,"volume":0,"delay":0,"floatShares":22730609,"shares":47225312,"eps":-2.42,"marketStatus":"停牌","marketStatusCode":2,"change":0,"latestTime":"05-10 12:20:31 EDT","open":2.65,"high":2.65,"low":2.65,"amount":7466452.157226,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.42,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1715371200000},"adr":0,"listingDate":1606971600000,"adjPreClose":2.65,"volumeRatio":0},"requestUrl":"/m/hq/s/KNTE","defaultTab":"news","newsList":[{"id":"2416649487","title":"BUZZ-向皮埃尔-法布尔出售癌症疗法后，Kinnate Bio 公司业绩上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2416649487","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2416649487?lang=zh_cn&edition=full","pubTime":"2024-03-01 22:40","pubTimestamp":1709304042,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    3月1日 - ** 药物开发商Kinnate Biopharma   股价上涨5.1%至2.60美元 ** 该公司将 (link) 其名为 exarafenib 的实验性癌症疗法出售给了法国的 Pierre Fabre Médicament，售价高达 3100万美元。** 该疗法正在进行早期和早中期试验** 交易完成后，KNTE 将获得 50 万美元，并在达到某些里程碑后获得 3050 万美元。** 股价在过去 12 个月中下跌了 50.8","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2411566281","title":"嗡嗡声--美国股票走势-Super Micro Computer、Kinsale Capital、Kinnate Biopharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2411566281","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2411566281?lang=zh_cn&edition=full","pubTime":"2024-02-16 23:53","pubTimestamp":1708098808,"startTime":"0","endTime":"0","summary":"        *      个股异动的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      2月16日 - 周五，华尔街主要股指走低，此前一份热度高于预期的生产者物价报告打压了市场对美国联邦储备委员会  即将降息的猜测。美东时间10:31，道琼斯工业平均指数  下跌0.27%，报38,669.2点。标准普尔500指数  下跌0.39%，报5,010.17点；纳斯达克综合指数  下跌0.75%，报15,787.267点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2402223705","title":"Kinnate Biopharma Inc盘中异动 股价大跌5.12%报2.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2402223705","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2402223705?lang=zh_cn&edition=full","pubTime":"2024-01-12 23:15","pubTimestamp":1705072544,"startTime":"0","endTime":"0","summary":"北京时间2024年01月12日23时15分，Kinnate Biopharma Inc股票出现异动，股价急速下挫5.12%。截至发稿，该股报2.41美元/股，成交量7.3406万股，换手率0.16%，振幅5.51%。Kinnate Biopharma Inc股票所在的生物技术行业中，整体涨幅为0.86%。Kinnate Biopharma Inc公司简介：Kinnate Biopharma Inc 是一家临床阶段的精准肿瘤学公司，专注于发现、设计和开发用于难以治疗的基因组定义癌症的小分子激酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024011223154487e652b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024011223154487e652b0&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kinnate.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0.1572},{"period":"6month","weight":1.1545},{"period":"1year","weight":-0.2385},{"period":"ytd","weight":0.1181}],"compareEarnings":[{"period":"1week","weight":0.03},{"period":"1month","weight":0.0016},{"period":"3month","weight":0.0378},{"period":"6month","weight":0.1806},{"period":"1year","weight":0.2599},{"period":"ytd","weight":0.0944}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kinnate Biopharma Inc.是一家生物制药公司，致力于发现和开发针对难以治疗的基因组定义的癌症的小分子激酶抑制剂。该公司的使命是通过为服务不足的人群开发产品来扩大靶向治疗的范围。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.08035},{"month":2,"riseRate":0.5,"avgChangeRate":-0.132211},{"month":3,"riseRate":0.75,"avgChangeRate":0.160008},{"month":4,"riseRate":0,"avgChangeRate":-0.268707},{"month":5,"riseRate":0.666667,"avgChangeRate":0.212663},{"month":6,"riseRate":0.333333,"avgChangeRate":0.094765},{"month":7,"riseRate":0,"avgChangeRate":-0.081431},{"month":8,"riseRate":0.666667,"avgChangeRate":0.043045},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.168745},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.156375},{"month":11,"riseRate":0.333333,"avgChangeRate":0.275034},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.099619}],"exchange":"NASDAQ","name":"Kinnate BioPharma Inc.","nameEN":"Kinnate BioPharma Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kinnate BioPharma Inc.(KNTE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kinnate BioPharma Inc.(KNTE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kinnate BioPharma Inc.,KNTE,Kinnate BioPharma Inc.股票,Kinnate BioPharma Inc.股票老虎,Kinnate BioPharma Inc.股票老虎国际,Kinnate BioPharma Inc.行情,Kinnate BioPharma Inc.股票行情,Kinnate BioPharma Inc.股价,Kinnate BioPharma Inc.股市,Kinnate BioPharma Inc.股票价格,Kinnate BioPharma Inc.股票交易,Kinnate BioPharma Inc.股票购买,Kinnate BioPharma Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kinnate BioPharma Inc.(KNTE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kinnate BioPharma Inc.(KNTE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况